Comparison between Command Polymers IPO and Infinium Pharmachem IPO.
Command Polymers IPO is a SME Fixed Price IPO proposed to list at BSE SME while Infinium Pharmachem IPO is a SME Fixed Price proposed to list at NSE SME.
| Command Polymers IPO | Infinium Pharmachem IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Aryaman Financial Services Ltd. | Swastika Investmart Ltd. |
| Registrar | Kfin Technologies Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Aryaman Capital Markets Ltd. | Swastika Investmart Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Command Polymers IPO is up to ₹6.72 Cr whereas the issue size of the Infinium Pharmachem IPO is up to ₹23.99 Cr. The final issue price of Command Polymers IPO is ₹28.00 per share and of Infinium Pharmachem IPO is ₹135.00 per share.
| Command Polymers IPO | Infinium Pharmachem IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹28.00 per share | ₹135.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹13.50 per share | |
| Market Lot Size | 4000 shares | 1000 shares |
| Fresh Issue Size | 24,00,000 shares | 17,81,000 shares |
| Fresh Issue Size (Amount) | up to ₹6.72 Cr | up to ₹23.99 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 24,00,000 shares | 17,81,000 shares |
| Issue Size Total (Amount) | up to ₹6.72 Cr | up to ₹23.99 Cr |
Command Polymers IPO opens on Mar 17, 2023, while Infinium Pharmachem IPO opens on Mar 31, 2023. The closing date of Command Polymers IPO and Infinium Pharmachem IPO is Mar 21, 2023, and Apr 05, 2023, respectively.
| Command Polymers IPO | Infinium Pharmachem IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Mar 17, 2023 | Mar 31, 2023 |
| Issue Close | Mar 21, 2023 | Apr 05, 2023 |
| Basis Of Allotment (Tentative) | Mar 24, 2023 | Apr 11, 2023 |
| Initiation of Refunds (Tentative) | Mar 27, 2023 | Apr 12, 2023 |
| Credit of Share (Tentative) | Mar 28, 2023 | Apr 13, 2023 |
| Listing date (Tentative) | Mar 29, 2023 | Apr 17, 2023 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Command Polymers IPO P/E ratio is 121.74, as compared to Infinium Pharmachem IPO P/E ratio of 7.83.
| Command Polymers IPO | Infinium Pharmachem IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 52.60 | 100 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 38.39 | 73.05 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 121.74 | 7.83 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹26.26 Cr. | ₹93.93 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 3.17 | 43.85 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 6.14 | 72 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 2.91 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹0.44 | ₹54.13 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 3.12 | 46.61 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Command Polymers IPO Retail Individual Investors (RII) are offered 12,00,000 shares while in Infinium Pharmachem IPO retail investors are offered 12,00,000 shares. Qualified Institutional Buyers (QIB) are offered in Command Polymers IPO and in Infinium Pharmachem IPO.
| Command Polymers IPO | Infinium Pharmachem IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 1,32,000 shares | 94,000 shares |
| QIB | ||
| NII | 12,00,000 shares | 8,70,000 shares |
| RII | 12,00,000 shares | 8,70,000 shares |
| Employee | 41,000 shares | |
| Others | ||
| Total | 24,00,000 shares | 17,81,000 shares |
Command Polymers IPO subscribed 1.39x in total, whereas Infinium Pharmachem IPO subscribed 1.92x.
| Command Polymers IPO | Infinium Pharmachem IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 1.81x | 1.94x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 0.98x | 2.00x |
| Employee (times) | 1.29x | |
| Other (times) | ||
| Total (times) | 1.39x | 1.92x |
